UBS Group AG - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260862. A total of 53 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2023$15,245
-42.1%
25,795
-61.8%
0.00%
Q4 2022$26,33667,528
+18868.5%
0.00%
Q3 2022$0
-100.0%
356
-98.5%
0.00%
Q2 2022$38,00024,0660.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,100,419$650,4580.10%
Virtu Financial LLC 58,883$350.00%
Simplicity Solutions, LLC 36,670$21,6760.00%
Renaissance Technologies 1,222,424$7230.00%
JPMORGAN CHASE & CO 293,036$173,0000.00%
COMMONWEALTH EQUITY SERVICES, LLC 38,359$220.00%
Gradient Investments LLC 63$370.00%
VANGUARD GROUP INC 2,427,778$1,435,0600.00%
Advisory Services Network, LLC 1$10.00%
Focused Wealth Management, Inc 222$1310.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders